Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital - Top-Institutions - MDSpire

Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital

  • By

  • Olga Rogozina

  • Susana Martín-López

  • Fiorela Cinthia Dueñas López

  • Zoraida del Solar Moreno

  • Larry Leiva Castrejon

  • Daniela Aguilar-Concepción

  • María Jiménez-González

  • Ana Martínez Feito

  • Miguel González-Muñoz

  • Elena Ramírez

  • May 15, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    La Paz University Hospital
    La Paz University Hospital

    Madrid, Spain

    Key Differentiators

    • Allergy and Immunology

  • #2

    Seattle Children’s Research Institute
    Seattle Children’s Research Institute

    Seattle, Washington

    Key Differentiators

    • Allergy and Immunology

  • #3

    Japan Association of Childhood Leukemia Study
    Japan Association of Childhood Leukemia Study

    Japan

    Key Differentiators

    • Allergy and Immunology

  • #4

    Children’s Oncology Group
    Children’s Oncology Group

    United States

    Key Differentiators

    • Allergy and Immunology

  • #5

    Children’s Cancer Group
    Children’s Cancer Group

    United States

    Key Differentiators

    • Allergy and Immunology

Original Source(s)

Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital

  • by Olga Rogozina, Susana Martín-López, Fiorela Cinthia Dueñas López, Zoraida del Solar Moreno, Larry Leiva Castrejon, Daniela Aguilar-Concepción, María Jiménez-González, Ana Martínez Feito, Miguel González-Muñoz, Elena Ramírez

  • May 15, 2026

Related Content

Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies